Skip to main content
. 2022 Mar 14;6(3):171–178. doi: 10.1002/jgh3.12723

Table 1.

Characteristics of patients with gastric cancer

No. of patients
Characteristic n (%)
Sex
Male 417 (65.7)
Female 218 (34.3)
Age 68.5 (30‐97)
Tumor location
EGJ 13 (2.0)
U 124 (19.5)
M 241 (38.0)
L 257 (40.5)
Macroscopic type
0‐I 16 (2.5)
0‐IIa 69 (10.9)
0‐IIb 6 (0.9)
0‐IIc 293 (46.1)
0‐III 2 (0.3)
1 9 (1.4)
2 102 (16.1)
3 88 (13.9)
4 17 (2.7)
5 33 (5.2)
Dissection of lymph nodes
D1 95 (15.1)
D1+ 288 (45.6)
D2 248 (39.3)
Pathological feature
tub1 159 (25.0)
tub2 167 (26.3)
por1 73 (11.5)
por2 160 (25.2)
sig 51 (8.0)
muc 15 (2.4)
pap 7 (1.1)
others 3 (0.5)
Stage
I 401 (63.2)
II 112 (17.6)
III 122 (19.2)
Surgical procedure
DG 410 (64.6)
TG 182 (28.7)
PG 43 (6.8)
Surgical approach
Open 254 (40.0)
Laparoscopic 381 (60.0)
Adjuvant chemotherapy
No 475 (74.8)
Yes 160 (25.2)
NLR
<2.75 431 (67.9)
≥2.75 204 (32.1)
PLR
<178 413 (65.0)
≥178 222 (35.0)
PI
0 579 (91.2)
1 52 (8.2)
2 4 (0.6)
PNI
≥45 469 (73.9)
40 ≤ PNI < 45 100 (15.7)
<40 66 (10.4)
Recurrence
No 547 (86.1)
Yes 88 (13.9)
Prognosis
Survival 447 (70.4)
Death 188 (29.6)

Data are presented as n (%) with the exception of age, which is presented as mean (range).

DG, distal gastrectomy; EGJ, esophagogastric junction; NLR, neutrophil/lymphocyte ratio; PG, proximal gastrectomy; PI, prognostic index; PLR, platelet/lymphocyte ratio; PNI, prognostic nutritional index; TG, total gastrectomy.